Rare condition

Hereditary angioedema type 2

3

studies recruiting now

as of 7 Sept 2026

21

studies registered in total

as of 7 Sept 2026

20

countries with a recruiting site

as of 7 Sept 2026

4 Mar 2026

most recent study posted

among recruiting studies

Recruiting trials

Showing the 3 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.

Search all Hereditary angioedema type 2 studies

Where recruiting studies are running

Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.

Keep watching

Get an email when a new Hereditary angioedema type 2 study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

About Hereditary angioedema type 2

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (SERPING1).

Treatments being studied

12 approved treatments and 9 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Approved: Berotralstat Hydrochloride (Orladeyo)Approved: Stanozolol (Stromba)Approved: Human C1-Esterase Inhibitor (Cetor)Approved: Flutemetamol F 18 (Vizamyl)Approved: Lanadelumab (Takhzyro)Approved: SebetralstatApproved: EcallantideApproved: Conestat Alfa (Ruconest)Approved: IcatibantApproved: Icatibant Acetate (Firazyr)Approved: DonidalorsenApproved: Berotralstat
Phase 3Avoralstat
Phase 3Sodium Chloride (Aqsia (balanced salt soln))
Phase 2Navenibart
Phase 2Hyaluronidase (Human Recombinant) (Cumulase)
Phase 1Digoxin (Digamex)
Phase 1Feniralstat
Phase 1Rosuvastatin
Phase 1Cyclosporine (Capimune)

+ 1 more in development

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).